Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

MERCK KGAA : Receives a Sell rating from Goldman Sachs

share with twitter share with LinkedIn share with facebook
09/21/2020 | 09:53am EDT

Goldman Sachs is negative on the stock with a Sell rating. The target price is still set at EUR 100.

© MarketScreener with dpa-AFX Analyser 2020

Stocks mentioned in the article
ChangeLast1st jan.
MERCK KGAA -3.77% 127.5 Delayed Quote.25.77%
THE GOLDMAN SACHS GROUP, INC. -1.47% 187.13 Delayed Quote.-17.39%
share with twitter share with LinkedIn share with facebook
All news about MERCK KGAA
10/29MERCK : Mammoth Biosciences Partner to Produce, Scale Up Covid-19 Test
DJ
10/28MERCK KGAA : Kepler Cheuvreux remains its Buy rating
MD
10/28MERCK : to Invest EUR20 Million in Display-Technology Production
DJ
10/27MERCK : MAVENCLAD® (cladribine tablets) is available through public drug plans f..
AQ
10/27MERCK KGAA : JP Morgan remains Neutral
MD
10/21MERCK KGAA : Morgan Stanley reaffirms its Neutral rating
MD
10/21MERCK KGAA : Bernstein reiterates its Neutral rating
MD
10/16Physiomics Wins Contracts With Existing Customers
DJ
10/15MERCK : Global Head of R&D for Healthcare to Retire
DJ
10/15Global Glycobiology Market to Rise at 14.64% between 2020 and 2027
AQ
More news
Financials
Sales 2020 17 302 M 20 160 M 20 160 M
Net income 2020 1 724 M 2 009 M 2 009 M
Net Debt 2020 10 812 M 12 599 M 12 599 M
P/E ratio 2020 31,8x
Yield 2020 1,02%
Capitalization 57 608 M 67 174 M 67 125 M
EV / Sales 2020 3,95x
EV / Sales 2021 3,66x
Nbr of Employees 57 523
Free-Float 29,7%
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 126,95 €
Last Close Price 132,50 €
Spread / Highest target 13,2%
Spread / Average Target -4,19%
Spread / Lowest Target -23,8%
EPS Revisions
Managers
NameTitle
Stefan Oschmann Chairman-Executive Board & CEO
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Christian Raabe Independent Member-Supervisory Board
Edeltraud Glänzer Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA25.77%67 174
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD108.70%21 161
KYOWA KIRIN CO., LTD.0.66%13 608
BETTA PHARMACEUTICALS CO., LTD.62.97%6 693
YUHAN CORPORATION25.79%3 381
RECIPHARM AB (PUBL)9.93%1 629